What is Apremilast?

Category: Prescription Drugs

Most popular types: Otezla

false

Apremilast is a medication that may be used as a treatment for certain types of psoriasis and psoriatic arthritis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Psoriatic arthritis 31 18
Psoriatic plaques (scaly patches) 12 10
Psoriasis 10 6
Arthritis pain in hip 1 0
Behcet's disease 1 0
Fingers curling 1 0

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 6
Mild 6
None 11

Commonly reported side effects and conditions associated with Apremilast

Side effect Patients Percentage
Diarrhea 5
Nausea 5
Back pain 1
Decreased appetite 1
Headaches 1
Joint pain in hands 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Apremilast

Dosage Patients Percentage
30 mg twice daily 5
60 mg twice daily 1

Why patients stopped taking Apremilast

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 5
Side effects too severe 4
Doctor's advice 3
Other 1
See all 8 patients who've stopped taking Apremilast

Duration

Currently taking Apremilast

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 3
5 - 10 years 1

Stopped taking Apremilast

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 3
6 months - 1 year 2
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 20
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 20
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 3
$25-49 1
< $25 10
Not specified 10

What people switch to and from

Patients started taking Apremilast after stopping:

Treatment Patients Percentage
Adalimumab (Humira) 7
Methotrexate (Trexall) 4
Clobetasol topical (Clobex) 3
Etanercept (Enbrel SureClick) 3
Betamethasone-calcipotriene topical (Dovobet) 1

Show all 12 treatments patients report switching from

Patients stopped taking Apremilast and switched to:

Treatment Patients Percentage
Adalimumab (Humira) 3
Etanercept (Enbrel SureClick) 1
Methotrexate (Trexall) 1
Secukinumab (Cosentyx) 1
Ustekinumab (Stelara) 1
Last updated:
There are no evaluations for Apremilast.